EP 124: Coronary Interventions and Evolving Technologies: The Year 2024 In Review with Dr Sukh Nijjer

Parallax by Ankur Kalra

In this week's Parallax, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2024. Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London. This episode focuses on recent developments in interventional cardiology, covering coronary interventions, new device technologies and challenging patient populations. Drs Kalra and Nijjer share their perspectives and experiences, offering valuable insights, practical tips and considerations when interpreting this year’s most impactful trials: REDUCE-AMI PREVENT FAVOR III ORBITA-COSMIC DANGer SHOCK SENIOR-RITA NOTION 3 What are the most impactful cardiovascular trials of 2024? How do Dr Kalra and Dr Nijjer integrate the latest information into their daily practices?